Unknown

Dataset Information

Cornerstones of CRISPR-Cas in drug discovery and therapy.


ABSTRACT: The recent development of CRISPR-Cas systems as easily accessible and programmable tools for genome editing and regulation is spurring a revolution in biology. Paired with the rapid expansion of reference and personalized genomic sequence information, technologies based on CRISPR-Cas are enabling nearly unlimited genetic manipulation, even in previously difficult contexts, including human cells. Although much attention has focused on the potential of CRISPR-Cas to cure Mendelian diseases, the technology also holds promise to transform the development of therapies to treat complex heritable and somatic disorders. In this Review, we discuss how CRISPR-Cas can affect the next generation of drugs by accelerating the identification and validation of high-value targets, uncovering high-confidenc

SUBMITTER: Fellmann C 

PROVIDER: S-EPMC5459481 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature